Our corporate partners

The International PNH Interest Group is a recognized by the US Internal Revenue Service as a not-for-profit organization. We are grateful to our Corporate Partners, who support our work.

If you have questions about or are interested in becoming a corporate partner and supporting our work, please contact us. Corporate membership is open to pharmaceutical and biotechnology companies interested or engaged in PNH research.

Representatives from investment and venture capital firms are not eligible for membership, given that IPIG is a not-for-profit scientific/educational organization whose purpose is to promulgate knowledge about and advocate for appropriate treatment and care of persons living with PNH.

Alexion Pharmaceuticals

Founding Partner http://www.alxn.com

Achillion Pharmaceuticals, Inc.

Corporate Partner http://www.achillion.com

Akari Therapeutics Plc

Corporate Partner http://www.akaritx.com

Alnylam Pharmaceuticals

Corporate Partner http://www.alnylam.com

Apellis Pharmaceuticals, Inc.

Corporate Partner http://www.apellis.com

Ra Pharmaceuticals, Inc.

Corporate Partner http://www.rapharma.com

Roche

Corporate Partner https://www.roche.com/

Help us expand our Resources

If you have information or resources you’d like to submit for inclusion on our IPIG website, our board will be happy to consider your submission.

Find out how to submit a resource